PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MRK vs. VTIP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between MRK and VTIP is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

MRK vs. VTIP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Vanguard Short-Term Inflation-Protected Securities ETF (VTIP). The values are adjusted to include any dividend payments, if applicable.

50.00%100.00%150.00%200.00%250.00%300.00%AugustSeptemberOctoberNovemberDecember2025
218.53%
27.14%
MRK
VTIP

Key characteristics

Sharpe Ratio

MRK:

-0.71

VTIP:

3.05

Sortino Ratio

MRK:

-0.85

VTIP:

4.68

Omega Ratio

MRK:

0.88

VTIP:

1.65

Calmar Ratio

MRK:

-0.55

VTIP:

7.06

Martin Ratio

MRK:

-1.09

VTIP:

18.68

Ulcer Index

MRK:

13.59%

VTIP:

0.28%

Daily Std Dev

MRK:

21.03%

VTIP:

1.74%

Max Drawdown

MRK:

-68.62%

VTIP:

-6.27%

Current Drawdown

MRK:

-25.27%

VTIP:

0.00%

Returns By Period

In the year-to-date period, MRK achieves a -1.57% return, which is significantly lower than VTIP's 0.58% return. Over the past 10 years, MRK has outperformed VTIP with an annualized return of 8.34%, while VTIP has yielded a comparatively lower 2.63% annualized return.


MRK

YTD

-1.57%

1M

-0.43%

6M

-21.00%

1Y

-15.14%

5Y*

5.64%

10Y*

8.34%

VTIP

YTD

0.58%

1M

0.83%

6M

2.62%

1Y

5.21%

5Y*

3.52%

10Y*

2.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MRK vs. VTIP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRK
The Risk-Adjusted Performance Rank of MRK is 1414
Overall Rank
The Sharpe Ratio Rank of MRK is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of MRK is 1313
Sortino Ratio Rank
The Omega Ratio Rank of MRK is 1313
Omega Ratio Rank
The Calmar Ratio Rank of MRK is 1414
Calmar Ratio Rank
The Martin Ratio Rank of MRK is 2020
Martin Ratio Rank

VTIP
The Risk-Adjusted Performance Rank of VTIP is 9696
Overall Rank
The Sharpe Ratio Rank of VTIP is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of VTIP is 9797
Sortino Ratio Rank
The Omega Ratio Rank of VTIP is 9696
Omega Ratio Rank
The Calmar Ratio Rank of VTIP is 9797
Calmar Ratio Rank
The Martin Ratio Rank of VTIP is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MRK vs. VTIP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Vanguard Short-Term Inflation-Protected Securities ETF (VTIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MRK, currently valued at -0.71, compared to the broader market-2.000.002.004.00-0.713.05
The chart of Sortino ratio for MRK, currently valued at -0.85, compared to the broader market-4.00-2.000.002.004.00-0.854.68
The chart of Omega ratio for MRK, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.65
The chart of Calmar ratio for MRK, currently valued at -0.55, compared to the broader market0.002.004.006.00-0.557.06
The chart of Martin ratio for MRK, currently valued at -1.09, compared to the broader market-10.000.0010.0020.00-1.0918.68
MRK
VTIP

The current MRK Sharpe Ratio is -0.71, which is lower than the VTIP Sharpe Ratio of 3.05. The chart below compares the historical Sharpe Ratios of MRK and VTIP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.71
3.05
MRK
VTIP

Dividends

MRK vs. VTIP - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 3.19%, more than VTIP's 2.69% yield.


TTM20242023202220212020201920182017201620152014
MRK
Merck & Co., Inc.
3.19%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%3.12%
VTIP
Vanguard Short-Term Inflation-Protected Securities ETF
2.69%2.70%3.36%6.84%4.68%1.20%2.29%2.45%1.52%0.76%0.00%0.82%

Drawdowns

MRK vs. VTIP - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.62%, which is greater than VTIP's maximum drawdown of -6.27%. Use the drawdown chart below to compare losses from any high point for MRK and VTIP. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-25.27%
0
MRK
VTIP

Volatility

MRK vs. VTIP - Volatility Comparison

Merck & Co., Inc. (MRK) has a higher volatility of 5.47% compared to Vanguard Short-Term Inflation-Protected Securities ETF (VTIP) at 0.47%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than VTIP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
5.47%
0.47%
MRK
VTIP
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab